United States · FDA National Drug Code directory
Quetiapine Fumarate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-767_6c68f74f-289f-4d3a-a0a7-ad6173b6628c
- Product NDC
- 31722-767
- Form
- TABLET, FILM COATED
- Composition / generic term
- Quetiapine Fumarate
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220616
- Source listing expiry
- 20261231
Source-listed ingredients
- QUETIAPINE FUMARATE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (31722-767-01) · 31722-767-01
- 500 TABLET, FILM COATED in 1 BOTTLE (31722-767-05) · 31722-767-05
- 100 BLISTER PACK in 1 CARTON (31722-767-32) / 10 TABLET, FILM COATED in 1 BLISTER PACK (31722-767-31) · 31722-767-32
- 100 BLISTER PACK in 1 CARTON (31722-767-34) / 10 TABLET, FILM COATED in 1 BLISTER PACK (31722-767-33) · 31722-767-34
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →